BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24744669)

  • 1. Secondary infections in cancer patients with febrile neutropenia.
    Azap A; Bozkurt GY; Yüksel MK; Kutlu H; Topçuoğlu P; Aypak A; Akan H
    Turk J Haematol; 2012 Sep; 29(3):254-8. PubMed ID: 24744669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode.
    Demirel A; Tabak F; Ar MC; Mete B; Öngören Ş; Yemişen M; Özaras R; Eşkazan E; Başlar Z; Mert A; Soysal T; Ferhanoğlu B; Aydın Y; Öztürk R
    Turk J Haematol; 2015 Sep; 32(3):243-50. PubMed ID: 25913035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of predictors of adverse outcome in febrile neutropenic episodes in pediatric oncology patients.
    Bothra M; Seth R; Kapil A; Dwivedi SN; Bhatnagar S; Xess I
    Indian J Pediatr; 2013 Apr; 80(4):297-302. PubMed ID: 23255077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A European Organization for Research and Treatment of Cancer-International Antimicrobial Therapy Group Study of secondary infections in febrile, neutropenic patients with cancer.
    Akova M; Paesmans M; Calandra T; Viscoli C;
    Clin Infect Dis; 2005 Jan; 40(2):239-45. PubMed ID: 15655741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of febrile neutropenic attacks of pediatric hematology-oncology patients.
    Kar YD; Özdemir ZC; Bör Ö
    Turk Pediatri Ars; 2017 Dec; 52(4):213-220. PubMed ID: 29483801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
    El-Maghraby SM; Moneer MM; Ismail MM; Shalaby LM; El-Mahallawy HA
    J Pediatr Hematol Oncol; 2007 Mar; 29(3):131-6. PubMed ID: 17356388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fever and neutropenia in children with malignant disease.
    Roguin A; Kasis I; Ben-Arush MW; Sharon R; Berant M
    Pediatr Hematol Oncol; 1996; 13(6):503-10. PubMed ID: 8940733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decision-tree derivation and external validation of a new clinical decision rule (DISCERN-FN) to predict the risk of severe infection during febrile neutropenia in children treated for cancer.
    Delebarre M; Gonzales F; Behal H; Tiphaine A; Sudour-Bonnange H; Lutun A; Abbou S; Pertuisel S; Thouvenin-Doulet S; Pellier I; Mansuy L; Piguet C; Paillard C; Blanc L; Thebaud E; Plantaz D; Blouin P; Schneider P; Guillaumat C; Simon P; Domenech C; Pacquement H; Le Meignen M; Pluchart C; Vérite C; Plat G; Martinot A; Duhamel A; Dubos F
    Lancet Child Adolesc Health; 2022 Apr; 6(4):260-268. PubMed ID: 34871572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Very early discharge versus early discharge versus non-early discharge in children with cancer and febrile neutropenia.
    Loeffen EA; Te Poele EM; Tissing WJ; Boezen HM; de Bont ES
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD008382. PubMed ID: 26899263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infections during Non-Neutropenic Episodes in Pediatric Cancer Patients-Results from a Prospective Study in Two Major Large European Cancer Centers.
    Schöning S; Barnbrock A; Bochennek K; Gordon K; Groll AH; Lehrnbecher T
    Antibiotics (Basel); 2022 Jul; 11(7):. PubMed ID: 35884154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with severe sepsis: prospective study of 94 neutropenic febrile episodes.
    Jeddi R; Achour M; Amor RB; Aissaoui L; Bouterâa W; Kacem K; Lakhal RB; Abid HB; BelHadjAli Z; Turki A; Meddeb B
    Hematology; 2010 Feb; 15(1):28-32. PubMed ID: 20132659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moxifloxacin versus levofloxacin for antibacterial prophylaxis in acute leukemia patients.
    Lee P; Knoebel RW; Pisano J; Pettit NN
    J Oncol Pharm Pract; 2019 Apr; 25(3):758-761. PubMed ID: 29310512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of severe adverse outcomes in febrile neutropenia of pediatric oncology patients at a single institute in Thailand.
    Suttitossatam I; Satayasai W; Sinlapamongkolkul P; Pusongchai T; Sritipsukho P; Surapolchai P
    Pediatr Hematol Oncol; 2020 Oct; 37(7):561-572. PubMed ID: 32543327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors associated with complications in patients with chemotherapy-induced febrile neutropenia in emergency department.
    Lynn JJ; Chen KF; Weng YM; Chiu TF
    Hematol Oncol; 2013 Dec; 31(4):189-96. PubMed ID: 23303687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors for risk stratification of adult cancer patients with chemotherapy-induced febrile neutropenia: a systematic review and meta-analysis.
    Lee YM; Lang D; Lockwood C
    JBI Libr Syst Rev; 2012; 10(40):2593-2657. PubMed ID: 27820557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutropenia-related costs in patients treated with first-line chemotherapy for advanced non-small cell lung cancer.
    Stokes ME; Muehlenbein CE; Marciniak MD; Faries DE; Motabar S; Gillespie TW; Lipscomb J; Knopf KB; Buesching DP
    J Manag Care Pharm; 2009 Oct; 15(8):669-82. PubMed ID: 19803556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical factors predicting bacteremia in low-risk febrile neutropenia after anti-cancer chemotherapy.
    Ha YE; Song JH; Kang WK; Peck KR; Chung DR; Kang CI; Joung MK; Joo EJ; Shon KM
    Support Care Cancer; 2011 Nov; 19(11):1761-7. PubMed ID: 20931237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of infection in patients with aplastic anemia and the emergence of Aspergillus as a major cause of death.
    Weinberger M; Elattar I; Marshall D; Steinberg SM; Redner RL; Young NS; Pizzo PA
    Medicine (Baltimore); 1992 Jan; 71(1):24-43. PubMed ID: 1549057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-index and invasive fungal infections (IFIs) in adult acute myeloid leukemia (AML) patients with the first episode of febrile neutropenia.
    Rattanathammethee T; Munsamai K; Punnachet T; Hantrakun N; Piriyakhuntorn P; Hantrakool S; Chai-Adisaksopha C; Rattarittamrong E; Tantiworawit A; Norasetthada L
    PLoS One; 2023; 18(5):e0286089. PubMed ID: 37216345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causative pathogens of fever in neutropenic patients at King Chulalongkorn Memorial Hospital.
    Roongpoovapatr P; Suankratay C
    J Med Assoc Thai; 2010 Jul; 93(7):776-83. PubMed ID: 20649055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.